Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Cutera is a medical devices business based in the US. Cutera shares (CUTR) are listed on the NASDAQ and all prices are listed in US Dollars. Cutera employs 461 staff and has a trailing 12-month revenue of around $250.7 million.
Finder Award
SoFi Invest
Robinhood
tastyworks
| Latest market close | $33.79 |
|---|---|
| 52-week range | $26.52 - $74.38 |
| 50-day moving average | $42.22 |
| 200-day moving average | $46.51 |
| Wall St. target price | $54.40 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.71 |
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $33.79 from 2023-01-30
| 1 week (2023-01-25) | -1.11% |
|---|---|
| 1 month (2022-12-30) | -23.59% |
| 3 months (2022-11-01) | -25.39% |
| 6 months (2022-08-01) | -26.05% |
| 1 year (2022-02-01) | -6.91% |
|---|---|
| 2 years (2021-02-01) | 39.86% |
| 3 years (2020-01-31) | 19.91% |
| 5 years (2018-01-31) | 49.6 |
Valuing Cutera stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cutera's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cutera's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 9.05. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Cutera's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
| Revenue TTM | $250.7 million |
|---|---|
| Gross profit TTM | $133.1 million |
| Return on assets TTM | -6.19% |
| Return on equity TTM | -221.6% |
| Profit margin | -31.31% |
| Book value | $0.79 |
| Market capitalisation | $670.3 million |
TTM: trailing 12 months
We're not expecting Cutera to pay a dividend over the next 12 months.
Over the last 12 months, Cutera's shares have ranged in value from as little as $26.52 up to $74.38. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cutera's is 1.6847. This would suggest that Cutera's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Cutera, Inc. , a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis. It also provides enlighten platform, a laser system that is used for tattoo removal, as well as to treat benign pigmented lesions and acne scars; excel HR platform, a hair removal solution for various skin types; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company distributes skincare products; and offers post-warranty services through extended service contracts or direct billing. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; and Pearl and Pearl Fractional hand pieces, as well as sells hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Learn about stock analysis and how to use it to find the right company to buy.